Skip to main content
eScholarship
Open Access Publications from the University of California

Amiloride Derivative Compound 10357 in the Treatment of B-Cell Acute Lymphoblastic Leukemia

The data associated with this publication are not available for this reason: N/A
Abstract

Compound 10357 is an amiloride derivative with potential promise as an adjunct to current chemotherapeutics. This study investigates the therapeutic efficacy of Compound 10357 in B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View